# Anchorage Capital Group, L.L.C.: Form 13F holdings

An institutional investment manager in NEW YORK, NY. SEC CIK 1300714.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $450.5m
- Positions: 3 (3 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1300714/000090514826003756/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [EQUIPMENTSHARE COM INC (EQPT)](/companies/eqpt.md) | COM CL A | $349.4m | 77.6% | 17,770,560 |  | Unchanged |
| [SENTINELONE INC (S)](/companies/s.md) | CL A | $83.8m | 18.6% | 4,937,053 |  | Unchanged |
| [GINKGO BIOWORKS HOLDINGS INC (DNA)](/companies/dna.md) | CL A NEW | $17.3m | 3.8% | 1,746,363 |  | Unchanged |

Source: SEC EDGAR, Form 13F-HR, accession 0000905148-26-003756. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.